• News
  • SAN DIEGO
  • Medical

Amgen, Illumina team on personalized medicine test

Biotech drugmaker Amgen and Illumina, a maker of genetic testing equipment, said Wednesday they are developing a test that will identify patients who might be helped by Amgen's colon cancer drug Vectibix.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
220.07
  -0.61  
- 0.28%
933,626,000
223.38
145.12

Insider Trade Data

Date Insider Shares Type Value
06/30/2015 Walt, David R 10,000 Sell $2,176,449
06/29/2015 Dadswell, Charles E 160 Sell $34,501
06/25/2015 Flatley, Jay T 25,000 Sell $5,508,403
06/25/2015 Flatley, Jay T 25,000 Exchange $815,750
06/24/2015 Bowman, Arthur Blaine 3,000 Sell $664,276

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
NAICS - 541711 - Research and Development in Biotechnology
Subscribe Today!